dapsone has been researched along with Body Weight in 14 studies
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
Excerpt | Relevance | Reference |
---|---|---|
" Dapsone, which is extensively used across the globe for dermatological disorders, arachnid bites, and for treatment of several bacterial, fungal, and parasitic diseases, could be affected by obesity." | 5.24 | Supervised Machine-Learning Reveals That Old and Obese People Achieve Low Dapsone Concentrations. ( Gumbo, T; Hall, RG; Leff, R; Meek, C; Pasipanodya, JG; Swancutt, MA, 2017) |
" Since prophylaxis with amodiaquine at 5 mg/kg weekly had failed, amodiaquine at a dose of 10mg/kg weekly and Maloprim (half a tablet or one tablet depending on body weight, which gave ranges of dapsone of 1." | 5.07 | Chemoprophylaxis against malaria in Papua New Guinea: a trial of amodiaquine and a combination of dapsone and pyrimethamine. ( Alpers, MP; Gibney, S; Gibson, FD; Heywood, PF; Jolley, D; Stace, J; Trenholme, KR; Vrbova, H, 1992) |
"A comparison of clofazimine and dapsone in the management of untreated lepromatous leprosy showed no significant differences between the two drugs in terms of morphological and bacterial indices." | 5.03 | Controlled clinical trial of clofazimine in untreated lepromatous leprosy. ( Jeevaratnam, A; Karat, AB; Karat, S; Rao, PS, 1971) |
"The ME7 scrapie-infected mice thus showed a characteristic complex of neurological and behavioural changes during the course of the disease that were not ameliorated by dapsone." | 1.31 | Early behavioural changes in scrapie-affected mice and the influence of dapsone. ( Deacon, RM; Guenther, K; Perry, VH; Rawlins, JN, 2001) |
" It is suggested that dapsone dosage be regulated to body weight and preferably not to exceed 1." | 1.28 | Investigations into the haemolytic effects of dapsone therapy in leprosy patients. ( Balakrishnan, S; Karthikeyan, S; Ramu, G, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (64.29) | 18.7374 |
1990's | 2 (14.29) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 1 (7.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hall, RG | 1 |
Pasipanodya, JG | 1 |
Swancutt, MA | 1 |
Meek, C | 1 |
Leff, R | 1 |
Gumbo, T | 1 |
ROY, AT | 1 |
Warren, G | 1 |
Peterson, CM | 1 |
Ahkavan, M | 1 |
Fernandez-Soto, ML | 1 |
Rowell, C | 1 |
Scott, BK | 1 |
Peterson, KP | 1 |
Guenther, K | 1 |
Deacon, RM | 1 |
Perry, VH | 1 |
Rawlins, JN | 1 |
Veggi, LM | 1 |
Crocenzi, FA | 1 |
Roma, MG | 1 |
Dawson, PA | 1 |
Pellegrino, JM | 1 |
Sánchez Pozzi, EJ | 1 |
Mottino, AD | 1 |
Peters, JH | 1 |
Gordon, GR | 1 |
Karat, AB | 2 |
Vrbova, H | 1 |
Gibney, S | 1 |
Gibson, FD | 1 |
Jolley, D | 1 |
Heywood, PF | 1 |
Stace, J | 1 |
Trenholme, KR | 1 |
Alpers, MP | 1 |
Balakrishnan, S | 1 |
Karthikeyan, S | 1 |
Ramu, G | 1 |
Grosset, JH | 1 |
Philip, PA | 1 |
Gayed, SL | 1 |
Rogers, HJ | 1 |
Crome, P | 1 |
Connor, B | 1 |
Shepard, CC | 1 |
Tolentino, JG | 1 |
McRae, DH | 1 |
Jeevaratnam, A | 1 |
Karat, S | 1 |
Rao, PS | 1 |
1 review available for dapsone and Body Weight
Article | Year |
---|---|
Pharmacokinetics in drug screening.
Topics: Animals; Biological Availability; Body Weight; Dapsone; Drug Evaluation, Preclinical; Humans; Lepros | 1987 |
4 trials available for dapsone and Body Weight
Article | Year |
---|---|
Supervised Machine-Learning Reveals That Old and Obese People Achieve Low Dapsone Concentrations.
Topics: Adult; Age Factors; Aged; Body Weight; Dapsone; Drug Dosage Calculations; Female; Humans; Male; Midd | 2017 |
Chemoprophylaxis against malaria in Papua New Guinea: a trial of amodiaquine and a combination of dapsone and pyrimethamine.
Topics: Antimalarials; Body Weight; Child; Child, Preschool; Dapsone; Drug Combinations; Drug Resistance; Fe | 1992 |
The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy.
Topics: Adult; Biopsy; Body Weight; Clinical Trials as Topic; Dapsone; Erythema Nodosum; Female; Humans; Inj | 1968 |
Controlled clinical trial of clofazimine in untreated lepromatous leprosy.
Topics: Adult; Anti-Inflammatory Agents; Body Weight; Clinical Trials as Topic; Costs and Cost Analysis; Dap | 1971 |
9 other studies available for dapsone and Body Weight
Article | Year |
---|---|
Diaminodiphenylsulphone (DDS) in leprosy: its effect on haemoglobin, weight, bacteriological index and reaction.
Topics: Body Weight; Body Weights and Measures; Dapsone; Hemoglobins; Leprosy; Sulfones | 1951 |
Dapsone and nerve damage.
Topics: Body Weight; Dapsone; Humans; Nervous System Diseases | 1980 |
Dapsone at onset of diabetes lowers glycated hemoglobin and delays death in NOD mice.
Topics: Age of Onset; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Body Weight; Dapsone; | 1998 |
Early behavioural changes in scrapie-affected mice and the influence of dapsone.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Avoidance Learning; Behavior, Animal; Body Weight; | 2001 |
Dapsone-induced cholestasis and impairment of bile salt output in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bile Acids and Salts; Biomarkers; Body Weight; Car | 2002 |
Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
Topics: Acetylation; Administration, Oral; Adult; Body Weight; Colorimetry; Dapsone; Female; Fluorometry; Hu | 1975 |
Investigations into the haemolytic effects of dapsone therapy in leprosy patients.
Topics: Adolescent; Adult; Bilirubin; Body Weight; Child; Dapsone; Drug Administration Schedule; Erythrocyte | 1989 |
Influence of age, sex and body weight on the dapsone acetylation phenotype.
Topics: Acetylation; Adult; Aging; Body Weight; Dapsone; Female; Humans; Male; Phenotype; Sex Factors | 1987 |
Case for diagnosis: leukocytoclastic vasculitis.
Topics: Anemia; Arteritis; Blood Sedimentation; Body Weight; Dapsone; Diagnosis, Differential; Humans; Leuko | 1973 |